glaucoma

ECPs don’t treat glaucoma aggressively enoughGlaucoma isn’t being treated aggressively enough, and eyecare practitioners are being too cautious when it comes to treating and diagnosing the disease—often at the patient’s expense.
Exploring SLT efficacy for prior incisional glaucoma surgerySelective laser trabeculoplasty is a reasonable treatment option to reduce IOP in glaucoma patients who have had previous glaucoma surgery.
Tablet-based tests putting detection of glaucoma at handAn iPad-based quick contrast sensitivity test had similar sensitivity and specificity to frequency-doubling technology.
Continuous IOP monitoring: Tools for addressing an unmet need
Continuous IOP monitoring: Tools for addressing an unmet needDevices for continuous IOP monitoring will address the need to better understand IOP levels and patterns in patients with glaucoma.
New technology predicts conversion to POAGClinicians can predict which patients with ocular hypertension are most likely to develop primary open-angle glaucoma (POAG) using short-wave automated perimetry, scanning laser polimetry, and confocal laser ophthalmoscopy, as well as the patient’s age, researchers said.
Microstent approval makes big news in glaucoma world
Microstent approval makes big news in glaucoma worldClinicians will soon have another treatment option for their patients with non-severe primary open-angle glaucoma (POAG). A micro invasive glaucoma surgical (MIGS) device (CyPass Micro-Stent, Alcon) has been approved by the FDA for use in patients with mild-moderate PAOG in conjunction with cataract surgery.
ABiC targets all sites of outflow resistanceAb-interno canaloplasty (ABiC) is a minimally invasive glaucoma surgery that accesses, catheterizes, and viscodilates all sites controlling aqueous outflow. When performed alone for uncontrolled glaucoma or with cataract surgery, it can result in reduced IOP and daily medication at follow-up through 12 months.
Glaucoma may not be the disease you think it is
Glaucoma may not be the disease you think it isClinicians continue to explore the relationship between IOP and cerebrospinal fluid pressure in glaucoma.
Aqueous drainage tube provides trabeculectomy-like efficacyIn a study including 23 eyes with a transscleral micro-lumen aqueous drainage tube after failing maximum tolerated medication, reductions in the mean IOP were observed as well as in the mean number of medications per day.
Multiple next-generation stents lead to better IOP controlThe use of multiple second-generation stent systems led to a 20% or higher reduction in IOP in a group of patients with mild-to-moderate, open-angle glaucoma.